1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine
C56H73N15O6S3 — CID 87810991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine
1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine (PubChem CID 87810991) has the molecular formula C56H73N15O6S3 and a molecular weight of 1148.50 g/mol. Its IUPAC name is 1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine.
Molecular Properties
| Compound Name | 1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine |
|---|---|
| PubChem CID | 87810991 |
| Molecular Formula | C56H73N15O6S3 |
| Molecular Weight | 1148.50 g/mol |
| Exact Mass | 1147.50 |
| IUPAC Name | 1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-N-(2-methoxyethyl)-N-methylpiperidin-4-amine;4-[3-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]sulfonylpropyl]morpholine |
| SMILES | COCCN(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1.O=S(=O)(CCCN1CCOCC1)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1 |
| InChI | InChI=1S/C29H38N8O4S2.C27H35N7O2S/c38-43(39,18-2-5-34-10-14-40-15-11-34)37-8-6-35(7-9-37)21-22-19-26-27(42-22)29(36-12-16-41-17-13-36)32-28(31-26)23-3-1-4-25-24(23)20-30-33-25;1-32(10-13-35-2)19-6-8-33(9-7-19)18-20-16-24-25(37-20)27(34-11-14-36-15-12-34)30-26(29-24)21-4-3-5-23-22(21)17-28-31-23/h1,3-4,19-20H,2,5-18,21H2,(H,30,33);3-5,16-17,19H,6-15,18H2,1-2H3,(H,28,31) |
| InChIKey | CFEKTQVKAABNSC-UHFFFAOYSA-N |
| XLogP | 5.85 |
| TPSA | 202.66 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 80 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1148.50 |
| LogP ≤ 5 | 5.85 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87810991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.